Get started
NEW JOURNEY HEALTHNN

NEW JOURNEY HEALTH

2.75CNYD
−0.04−1.43%
At close at 08:49 GMT
CNY
No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Forecast Seasonals

002219 fundamentals

Key facts

Market capitalization‪9.47 B‬CNY
Dividend yield (indicated)—
Price to earnings Ratio (TTM)189.80
Basic EPS (TTM)0.01CNY
Founded2001
Employees (FY)‪7.89 K‬
CEO—
Websitenjhtg.com
About

New Journey Health Technology Group Co., Ltd. provides medical services, pharmaceutical manufacturing, daily chemicals and health products business. Its products include tablets, syrups, capsules, mixtures, pills and others. The company was founded on September 30, 2001 and is headquartered in Beijing, China.

Ownership
‪‪3.27 B‬‬
Free Float shares
‪‪1.99 B‬‬ (60.88%)
Closely held shares
‪‪1.28 B‬‬ (39.12%)
Free Float shares
‪‪1.99 B‬‬ (60.88%)
Closely held shares
‪‪1.28 B‬‬ (39.12%)
Capital structure
Market cap
‪‪9.47 B‬‬
Debt
‪‪1.88 B‬‬
Minority interest
‪‪41.50 M‬‬
Cash & equivalents
‪‪437.98 M‬‬
Enterprise value
‪‪10.96 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪9.47 B‬‬
Price to earning ratio (P/E)
189.80x
Price to sales ratio (P/S)
2.54x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
189.80x
Price to sales ratio (P/S)
2.54x
Valuation ratios
‪0.00‬
‪0.90‬
‪1.80‬
‪2.70‬
‪3.60‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪90.00‬
‪180.00‬
‪270.00‬
‪360.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−4%‬
‪−2%‬
‪0%‬
‪2%‬
‪4%‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−400.00 M‬‬
‪0.00‬
‪‪400.00 M‬‬
‪‪800.00 M‬‬
‪‪1.20 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−300.00 M‬‬
‪0.00‬
‪‪300.00 M‬‬
‪‪600.00 M‬‬
‪‪900.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−300.00 M‬‬
‪0.00‬
‪‪300.00 M‬‬
‪‪600.00 M‬‬
‪‪900.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Medical Services
Pharmaceutical and Medical Product
Parent and Investment Companies
Other Business
By country
Period: 2023
China

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
2016
2017
2023
2024
‪0.00‬
‪‪1.10 B‬‬
‪‪2.20 B‬‬
‪‪3.30 B‬‬
‪‪4.40 B‬‬
Actual
Estimate
Earnings
Next:Apr 18, 2025
2016
2017
2023
2024
‪0.00‬
‪0.10‬
‪0.20‬
‪0.30‬
‪0.40‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

002219 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company

Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−700.00 M‬‬
‪0.00‬
‪‪700.00 M‬‬
‪‪1.40 B‬‬
‪‪2.10 B‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪1.10 B‬‬
‪‪2.20 B‬‬
‪‪3.30 B‬‬
‪‪4.40 B‬‬
Assets
Liabilities